Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

02. April 2026 08:31 ET | Quelle: Mama’s Creations, Inc.

Mama’s Creations Appoints Fred Halvin to Board of Directors

Veteran Corporate Development Executive Brings 37 Years of M&A, Strategic Growth and Food Industry Experience at Hormel Foods to the Board EAST RUTHERFORD, NJ, April 02, 2026 (GLOBE NEWSWIRE)...
02. April 2026 08:30 ET | Quelle: Biodexa Pharmaceuticals PLC

Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies

April 2, 2026 Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) (“Biodexa” or “Company”), a clinical stage...
02. April 2026 08:30 ET | Quelle: Cycurion

Cycurion Goes on Offense: Initiates Legal Action and Seeks Millions in Damages Against ACCESS Newswire and Those Responsible for Disseminating the Unauthorized and Fraudulent Release

"As a publicly traded company, we will not tolerate attacks on our integrity or attempts to deceive our investors."
02. April 2026 08:30 ET | Quelle: Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics Announces Strategic Partnership with TechForce Robotics to Commercialize PDAOAI-Enhanced GMP Robotics Platform

LOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”), a clinical-stage biotechnology company focused on oncology and AI-driven...
02. April 2026 08:30 ET | Quelle: Onconetix, Inc.

Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update

Realbotix Announces Expected Delivery of 19 Robots in March, April, and May 2026 as it Scales Production Capacity; Onconetix recently Entered into a Definitive Agreement to Acquire Realbotix LLC, a...
02. April 2026 08:30 ET | Quelle: SurgePays, Inc.

SurgePays Launches Stored Value and Loyalty Platform Across Retail Network

BARTLETT, Tenn., April 02, 2026 (GLOBE NEWSWIRE) -- SurgePays, Inc. (NASDAQ: SURG) (“SurgePays” or the “Company”), a wireless and fintech technology company connecting subprime and underserved...
02. April 2026 08:30 ET | Quelle: Quantum BioPharma

Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied

TORONTO, April 02, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a...
02. April 2026 08:30 ET | Quelle: Intelligent Bio Solutions, Inc.

Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market

Study results finalized on schedule support FDA clearance and planned U.S. commercial launch Company advances second phase of clinical program for 510(k) submission with method comparison, usability,...
02. April 2026 08:30 ET | Quelle: Abeona Therapeutics Inc.

Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York

CLEVELAND, April 02, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of NewYork-Presbyterian/Columbia University Irving Medical Center in New York, NY as...
02. April 2026 08:30 ET | Quelle: Ultragenyx Pharmaceutical Inc.

Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)

If approved, UX111 will be the first approved therapy for the treatment of Sanfilippo syndrome Type A, a rare disease affecting young children that leads to progressive, irreversible neurodegeneration...

Nächste Seite